Sofosbuvir Reduces Transplant Need and Mortality Rates in Hepatitis C Patients, Study Finds
Sofosbuvir significantly reduces the risk of death and the need for liver transplant in patients with hepatitis C who suffer from advanced stages of liver disease.
What to Eat If You Have Hepatitis C
If hepatitis causes liver damage, a person may need to modify their diet.
Pregnancy Rates on the Rise Among Women with Chronic Liver Disease
In addition, the proportion of full‐term pregnancies has increased significantly over that time period, and most women had favorable pregnancy outcomes.
Cutting Back on Carbs Could Help Treat Fatty Liver Disease
Researchers found that just 2 weeks of a carb-restricted diet reduced levels of liver fat and improved other markers of cardiometabolic health in a small number of individuals living with non-alcoholic fatty liver disease (NAFLD) .
Researchers Develop Method to Identify Splicing-based Biomarkers for Liver Cancer
Researchers at Cold Spring Harbor Laboratory (CSHL), led by CSHL Professor Adrian Krainer, now report in Genome Research that they have developed a method for identifying splicing-based biomarkers for the most common form of liver cancer.
Do You Forget Your Daily Hepatitis B Antiviral？ Why We “Forget” Our Meds, and How to Improve Compliance
According to experts, whether we are “medication compliant” or not depends on how much trust we have in our doctors.
Long-Term Safety of Oral Nucleos(t)ide Analogs for Patients With Chronic Hepatitis B: A Cohort Study of 53,500 Subjects
Widespread and long-term use of oral nucleos(t)ide analogs (NAs) to treat chronic hepatitis B (CHB) brings about safety data in a real-life setting.
When to Get Tested for Hepatitis C after Exposure
The body begins to release antibodies after the virus particles called HCV RNA are detectable.
CDC National Progress Report on Hepatitis Elimination Reveals Rise in Acute HBV Infections and Low Birth Dose Vaccination Rates in the U.S.
The CDC report reveals continuing challenges in addressing the public health threat of hepatitis B, with new increases in rates of acute hepatitis B infection among adults, particularly those between the ages of 30 and 59 years.
Significance of Day-1 Viral Response of Hepatitis C Virus in Patients with Chronic Hepatitis C Receiving Direct-acting Antiviral Therapy
We evaluated the significance of very early viral response after the start of therapy, which indicates direct HCV response to the drugs, on therapeutic outcome.